Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Pathophysiological Implications of the Incretin Hormones in Patients With Liver Disease With and Without Diabetes

This study has been completed.
Information provided by (Responsible Party):
Jonatan I Bagger, University Hospital, Gentofte, Copenhagen Identifier:
First received: December 5, 2011
Last updated: July 9, 2014
Last verified: July 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2014
  Primary Completion Date: May 2013 (Final data collection date for primary outcome measure)